Get started
Author

Jessica Hartmann

Observed names: Hartmann, Jessica, J Hartmann
ORCID: 0000-0001-9372-8954
Observed ORCID: 0000-0001-9372-8954
OpenAlex ID: A5076760558
Clinical development of CAR T cells—challenges and opportunities in translating innovative treatment concepts
2017 · Jessica Hartmann, Martina Schüßler‐Lenz, et al. · EMBO Molecular Medicine · 553
PDF
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
2021 · Nawid Albinger, Jessica Hartmann, et al. · Gene Therapy · 236
PDF
High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
2020 · Stephan Müller, Tobias Bexte, et al. · Frontiers in Immunology · 119
PDF
Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment
2016 · Ruben R. Bender, Anke Muth, et al. · PLoS Pathogens · 113
PDF
Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4
2020 · Arezoo Jamali, Jamshid Hadjati, et al. · Frontiers in Immunology · 71
PDF
Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors
2019 · Arezoo Jamali, Laura Kapitza, et al. · Molecular Therapy — Methods & Clinical Development · 69
Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8
2021 · Alexander Michels, Annika M. Frank, et al. · Molecular Therapy — Methods & Clinical Development · 61
PDF
Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
2019 · Johanna Reul, Janina Frisch, et al. · Frontiers in Oncology · 60
PDF
A Library-Based Screening Strategy for the Identification of DARPins as Ligands for Receptor-Targeted AAV and Lentiviral Vectors
2018 · Jessica Hartmann, Robert C. Münch, et al. · Molecular Therapy — Methods & Clinical Development · 50
A Soluble Fragment of the Tumor Antigen BCL2-associated Athanogene 6 (BAG-6) Is Essential and Sufficient for Inhibition of NKp30 Receptor-dependent Cytotoxicity of Natural Killer Cells
2013 · Janina Binici, Jessica Hartmann, et al. · Journal of Biological Chemistry · 49
Immunotherapy with NK cells: recent developments in gene modification open up new avenues
2020 · Lisa Marie Reindl, Nawid Albinger, et al. · OncoImmunology · 48
PDF
The Stalk Domain and the Glycosylation Status of the Activating Natural Killer Cell Receptor NKp30 Are Important for Ligand Binding
2012 · Jessica Hartmann, Thuy-Van Tran, et al. · Journal of Biological Chemistry · 45
Genetic in vivo engineering of human T lymphocytes in mouse models
2021 · Tatjana Weidner, Shiwani Agarwal, et al. · Nature Protocols · 41
PDF
CD8-Specific Designed Ankyrin Repeat Proteins Improve Selective Gene Delivery into Human and Primate T Lymphocytes
2020 · Annika M. Frank, Tatjana Weidner, et al. · Human Gene Therapy · 34
GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
2019 · Jessica Hartmann, Frederic B. Thalheimer, et al. · Molecular Therapy — Methods & Clinical Development · 26
PDF
CAR T-cell-associated secondary malignancies challenge current pharmacovigilance concepts
2025 · Philipp Berg, Gabriele Ruppert-Seipp, et al. · EMBO Molecular Medicine · 21
Assembly and Function of the Major Histocompatibility Complex (MHC) I Peptide-loading Complex Are Conserved Across Higher Vertebrates
2014 · Andreas Hinz, Johanna Jedamzick, et al. · Journal of Biological Chemistry · 20
PDF
Displaying Tetra‐Membrane Spanning Claudins on Enveloped Virus‐Like Particles for Cancer Immunotherapy
2017 · Irene C. Schneider, Jessica Hartmann, et al. · Biotechnology Journal · 16
The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex
2016 · Stefanie Memmer, Sandra Weil, et al. · Journal of Biological Chemistry · 14
PDF
CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes
2023 · Laura Kapitza, Naphang Ho, et al. · Frontiers in Immunology · 13
Designed Ankyrin Repeat Protein (DARPin) to target chimeric antigen receptor (CAR)-redirected T cells towards CD4+ T cells to reduce the latent HIV+ cell reservoir
2020 · Lea Patasic, Janna Seifried, et al. · Medical Microbiology and Immunology · 11
PDF
Homo-oligomerization of the Activating Natural Killer Cell Receptor NKp30 Ectodomain Increases Its Binding Affinity for Cellular Ligands
2013 · Julia Herrmann, Hannah Berberich, et al. · Journal of Biological Chemistry · 11
PDF
FcγRIIA-specific DARPins as novel tools in blood cell analysis and platelet aggregation
2023 · Vanessa Riechert, Sascha Hein, et al. · Journal of Biological Chemistry · 7
PDF
Chimäre Antigenrezeptoren (CARs) in der Onkologie: eine Übersicht zu klinischer Anwendung und neuen Entwicklungen
2020 · Alexander Michels, Jessica Hartmann, et al. · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · 7
PDF
CAR-T-Zell-Therapie: Aussichten und Risiken
2018 · Christian J. Buchholz, Jessica Hartmann, et al. · Deutsches Ärzteblatt · 7
Works count: 31
Citation count: 1,705
H-index: 17
I10-index: 22
Year
Topic
Type